Xylem Statistics
Total Valuation
Xylem has a market cap or net worth of $29.03 billion. The enterprise value is $30.35 billion.
| Market Cap | 29.03B |
| Enterprise Value | 30.35B |
Important Dates
The next estimated earnings date is Thursday, May 1, 2025, before market open.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | Feb 18, 2025 |
Share Statistics
Xylem has 243.05 million shares outstanding. The number of shares has increased by 11.62% in one year.
| Current Share Class | 243.05M |
| Shares Outstanding | 243.05M |
| Shares Change (YoY) | +11.62% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 94.91% |
| Float | 241.45M |
Valuation Ratios
The trailing PE ratio is 32.72 and the forward PE ratio is 25.65. Xylem's PEG ratio is 2.14.
| PE Ratio | 32.72 |
| Forward PE | 25.65 |
| PS Ratio | 3.38 |
| Forward PS | 3.29 |
| PB Ratio | 2.73 |
| P/TBV Ratio | 102.58 |
| P/FCF Ratio | 30.82 |
| P/OCF Ratio | 22.98 |
| PEG Ratio | 2.14 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.03, with an EV/FCF ratio of 32.22.
| EV / Earnings | 34.10 |
| EV / Sales | 3.54 |
| EV / EBITDA | 18.03 |
| EV / EBIT | 27.08 |
| EV / FCF | 32.22 |
Financial Position
The company has a current ratio of 1.75, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.75 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.34 |
| Debt / FCF | 2.59 |
| Interest Coverage | 25.48 |
Financial Efficiency
Return on equity (ROE) is 8.45% and return on invested capital (ROIC) is 5.34%.
| Return on Equity (ROE) | 8.45% |
| Return on Assets (ROA) | 4.30% |
| Return on Invested Capital (ROIC) | 5.34% |
| Return on Capital Employed (ROCE) | 7.92% |
| Revenue Per Employee | $372,261 |
| Profits Per Employee | $38,696 |
| Employee Count | 23,000 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 5.31 |
Taxes
In the past 12 months, Xylem has paid $197.00 million in taxes.
| Income Tax | 197.00M |
| Effective Tax Rate | 18.12% |
Stock Price Statistics
The stock price has decreased by -7.68% in the last 52 weeks. The beta is 1.08, so Xylem's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -7.68% |
| 50-Day Moving Average | 125.46 |
| 200-Day Moving Average | 128.85 |
| Relative Strength Index (RSI) | 39.04 |
| Average Volume (20 Days) | 1,626,672 |
Short Selling Information
The latest short interest is 2.99 million, so 1.23% of the outstanding shares have been sold short.
| Short Interest | 2.99M |
| Short Previous Month | 3.44M |
| Short % of Shares Out | 1.23% |
| Short % of Float | 1.24% |
| Short Ratio (days to cover) | 1.99 |
Income Statement
In the last 12 months, Xylem had revenue of $8.56 billion and earned $890.00 million in profits. Earnings per share was $3.65.
| Revenue | 8.56B |
| Gross Profit | 3.21B |
| Operating Income | 1.12B |
| Pretax Income | 838.00M |
| Net Income | 890.00M |
| EBITDA | 1.68B |
| EBIT | 1.12B |
| Earnings Per Share (EPS) | $3.65 |
Balance Sheet
The company has $1.12 billion in cash and $2.44 billion in debt, giving a net cash position of -$1.32 billion or -$5.44 per share.
| Cash & Cash Equivalents | 1.12B |
| Total Debt | 2.44B |
| Net Cash | -1.32B |
| Net Cash Per Share | -$5.44 |
| Equity (Book Value) | 10.88B |
| Book Value Per Share | 43.80 |
| Working Capital | 1.76B |
Cash Flow
In the last 12 months, operating cash flow was $1.26 billion and capital expenditures -$321.00 million, giving a free cash flow of $942.00 million.
| Operating Cash Flow | 1.26B |
| Capital Expenditures | -321.00M |
| Free Cash Flow | 942.00M |
| FCF Per Share | $3.88 |
Margins
Gross margin is 37.51%, with operating and profit margins of 13.09% and 10.39%.
| Gross Margin | 37.51% |
| Operating Margin | 13.09% |
| Pretax Margin | 12.70% |
| Profit Margin | 10.39% |
| EBITDA Margin | 19.66% |
| EBIT Margin | 13.09% |
| FCF Margin | 11.00% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 1.34%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 1.34% |
| Dividend Growth (YoY) | 9.63% |
| Years of Dividend Growth | 10 |
| Payout Ratio | 43.84% |
| Buyback Yield | -11.62% |
| Shareholder Yield | -10.28% |
| Earnings Yield | 3.07% |
| FCF Yield | 3.24% |
Analyst Forecast
The average price target for Xylem is $149.89, which is 25.49% higher than the current price. The consensus rating is "Buy".
| Price Target | $149.89 |
| Price Target Difference | 25.49% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 5.50% |
| EPS Growth Forecast (5Y) | 13.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Xylem has an Altman Z-Score of 4.49 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.49 |
| Piotroski F-Score | 6 |